https://www.fool.com/investing/2024/08/07/chipotle-spotify-upsinvestors-review-some-big-name/?source=iedfolrf0000001
Aug 07, 2024 - And of course we're still talking about that IT outage.
0
fool:-3292975074967585760
0
https://www.zacks.com/stock/news/2318359/wynn-resorts-wynn-q2-earnings-revenues-lag-both-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2318359
Aug 07, 2024 - Wynn Resorts' (WYNN) second-quarter 2024 results reflect performance strengths across its Wynn Palace, Wynn Macau and Las Vegas operations, partially offset by soft contributions from the Encore Boston Harbor operation.
zc:-5226381130207858597
0
https://www.zacks.com/stock/news/2318310/masimo-masi-q2-earnings-beat-estimates-gross-margin-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2318310
Aug 07, 2024 - Strength in Healthcare revenues drive Masimo's (MASI) second-quarter results.
zc:7811126478128292233
0
https://seekingalpha.com/news/4136130-wixcom-ticks-up-as-ai-wix-studio-aid-strong-q2-results-guidance?source=feed_tag_israel
Aug 07, 2024 - Wix.com (WIX) gained nearly 6% in early trading on Wednesday. Read for more.
0
sa:-4333358387940929214
0
https://www.rttnews.com/story.aspx?Id=3467197
Aug 07, 2024 - GEO Group, Inc. (GEO), a diversified government service provider, on Wednesday issued outlook for third quarter as well as fourth quarter, and updated fiscal 2024 guidance. This was after reporting a loss in its second quarter, compared to prior year's profit, despite revenue growth.
0
rttnews:-496160346260699315
0
https://seekingalpha.com/news/4135272-td-cowen-ups-spero-to-buy-cites-added-clarity-on-catalyst-timing?source=feed_sector_healthcare
Aug 06, 2024 - TD Cowen has upgraded Spero Therapeutics (SPRO) to buy, citing new clarity on catalyst timing and optimism for upcoming Phase 2 data on its drug SPR720. Read more here.
0
sa:-1938032606064133741
0
https://www.zacks.com/stock/news/2316387/acadia-healthcare-achc-shares-up-12-on-q2-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2316387
Aug 05, 2024 - Acadia Healthcare's (ACHC) Q2 results reflect higher revenue per patient day and increased patient days. It currently estimates 2024 adjusted EPS within $3.45-$3.65 compared with the earlier view of $3.40-$3.70.
zc:6419591685242390817
0
https://www.zacks.com/stock/news/2316360/eog-resources-eog-tops-on-q2-earnings-ups-24-output-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2316360
Aug 05, 2024 - Higher oil-equivalent production volumes, increased crude oil and condensates, and NGL price realizations aid EOG Resources' (EOG) earnings in Q2.
zc:9145176298421468692
0
https://www.zacks.com/stock/news/2316300/fulcrum-therapeutics-inc-fulc-is-up-7-55-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2316300
Aug 05, 2024 - Does Fulcrum Therapeutics, Inc. (FULC) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:2204269531253465330
0
https://www.zacks.com/stock/news/2316298/pc-connection-cnxn-is-up-5-70-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2316298
Aug 05, 2024 - Does PC Connection (CNXN) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-8121623997047416806
0